Records containing: Macular Oedema
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-17Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery
-
CLINICAL_TRIALS study record update · 2025-09-10Evaluation of Morphological and Functional Changes in Eyes With Epiretinal Membrane After Vitrectomy
-
CLINICAL_TRIALS study record update · 2024-05-06Prospective Non-randomised Exploratory Study to Assess the Safety and Efficacy of Aflibercept (Eylea) in Cystoid Macular Oedema (CMO) Associated With Retinitis Pigmentosa (RP)
-
CLINICAL_TRIALS study record update · 2014-09-30Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment. A UK, 18-month, Prospective, Open-label, Multicentre, Single-arm, Phase IIIb Study With 12-month Primary Endpoint, Assessing the Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Diabetic Macular Oedema.
-
CLINICAL_TRIALS study record update · 2013-05-27ClinicalTrials.gov study NCT01566526
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2006-11-23Off-Label,Intravitreal Use of Bevacizumab for Retinal Disorders